DN
David Nierengarten Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
41
Avg Return
Past Year
Past Year
27%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
78.3%
Neutral
21.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Technology
Consumer Discretionary
Residential Construction
Restaurants
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Technology
Solar
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Upgraded
| $5.50 |
0%
downside
| 2 | +2.2% |
0
%
| 16 Dec ‘25 23 days ago |
|
|
|
Outperform
Reiterated
| $25 |
88%
upside
| 3 | +7.8% |
0
%
| 11 Dec ‘25 28 days ago |
|
|
|
Outperform
Reiterated
| $20 |
137%
upside
| 1 | -23% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $1,000 |
26%
upside
| 6 | +8.1% |
0
%
| 14 Nov ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $7 |
33%
downside
| 2 | – |
–
| 7 Nov ‘25 2 months ago |
|
|
|
Outperform
Upgraded
| $7 |
560%
upside
| 2 | -36% |
0
%
| 27 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $110 |
39%
upside
| 1 | +6.6% |
0
%
| 17 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $70 |
60%
upside
| 2 | +68% |
0
%
| 15 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $44 |
5%
upside
| 2 | +44% |
0
%
| 13 Oct ‘25 2 months ago |
|
|
|
Outperform
Reiterated
| $6 |
29%
downside
| 4 | +47% |
0
%
| 13 Oct ‘25 2 months ago |
|
|
|
Outperform
Reiterated
| $115 |
12%
upside
| 1 | +27% |
0
%
| 8 Sep ‘25 4 months ago |
|
|
|
Outperform
Initiated
| $4 |
14%
downside
| 1 | +199% |
0
%
| 8 Sep ‘25 4 months ago |
|
|
|
Outperform
Reiterated
| $26 |
83%
upside
| 2 | +42% |
0
%
| 2 Sep ‘25 4 months ago |
|
|
|
Outperform
Reiterated
| $22 |
188%
upside
| 3 | -23% |
0
%
| 28 Aug ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $276 |
3,929%
upside
| 1 | – |
–
| 25 Jul ‘25 5 months ago |
|
|
|
Neutral
Reiterated
| $8 |
37%
downside
| 1 | – |
–
| 26 Jun ‘25 6 months ago |
|
|
|
Outperform
Reiterated
| $11 |
291%
upside
| 2 | +17% |
0
%
| 23 Jun ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $129 |
0%
downside
| 3 | +8.8% |
0
%
| 2 Jun ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| $12 | – | 1 | – |
–
| 28 May ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $27 |
82%
upside
| 1 | – |
–
| 16 Apr ‘25 8 months ago |
|
|
|
Outperform
Reiterated
| $33 |
61%
upside
| 1 | +139% |
0
%
| 20 Mar ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| $2 |
83%
downside
| 1 | – |
–
| 14 Mar ‘25 10 months ago |
|
|
|
Outperform
Reiterated
| $31 |
87%
upside
| 2 | +15% |
0
%
| 12 Feb ‘25 11 months ago |
|
|
|
Outperform
Reiterated
| $77 |
64%
upside
| 1 | -15% |
0
%
| 12 Feb ‘25 11 months ago |
|